Topics

No keywords indexed for this article. Browse by subject →

References
9
[1]
Grunebaum "Updated management guidelines for adenosine deaminase deficiency" J Allergy Clin Immunol Pract (2023) 10.1016/j.jaip.2023.01.032
[2]
Santisteban "Evolving spectrum of adenosine deaminase (ADA) deficiency: assessing genotype pathogenicity according to expressed ADA activity of 46 variants" J Allergy Clin Immunol (2025) 10.1016/j.jaci.2024.08.014
[3]
Grever "The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy" Blood (1981) 10.1182/blood.v57.3.406.406
[4]
Siaw "ATP depletion as a consequence of adenosine deaminase inhibition in man" Proc Natl Acad Sci U S A (1980) 10.1073/pnas.77.10.6157
[5]
Bagnara "Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells" Proc Natl Acad Sci U S A (1982) 10.1073/pnas.79.8.2673
[6]
Morgan "Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency" Clin Exp Immunol (1987)
[7]
Chottiner "Erythrocyte adenosine deaminase overproduction in hereditary hemolytic anemia" Blood (1989) 10.1182/blood.v74.1.448.448
[8]
Valentine "Hereditary hemolytic anemia with increased red cell adenosine deaminase (45- to 70-fold) and decreased adenosine triphosphate" Science (1977) 10.1126/science.836588
[9]
Fairman "Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization" Nat Struct Mol Biol (2011) 10.1038/nsmb.2007
Metrics
0
Citations
9
References
Details
Published
Apr 01, 2026
Vol/Issue
157(4)
Pages
993-995
License
View
Cite This Article
Pawan Bali, Susan J. Kelly, Ines Santisteban, et al. (2026). Reassessing AXP depletion due to inherited deficiency of adenosine deaminase 1. Journal of Allergy and Clinical Immunology, 157(4), 993-995. https://doi.org/10.1016/j.jaci.2025.12.1004